FattaBNahabMDFAAN, FANA

Neurology • San Diego, CA

Movement Disorder, Neuroimaging, Neurodegenerative

Voluntary Professor of Neurosciences

Join to view full profile

Dr. Nahab is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nahab's full profile

Already have an account?

Office
4510 Executive Drive
Suite 325
San Diego, CA 92121
Phone+1 858-657-8540

Fax+1 858-657-8557

Education & Training

National Institutes of HealthFellowship, 2004 - 2008
Loma Linda University Health Education ConsortiumResidency, Neurology, 2001 - 2004
Loma Linda University Health Education ConsortiumInternship, Transitional Year, 2000 - 2001
Loma Linda University School of MedicineClass of 2000

Certifications & Licensure

CA State Medical License 2001 - 2025
FL State Medical License 2008 - 2020
MD State Medical License 2005 - 2007
IL State Medical License 2003 - 2005
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Octanol to Treat Essential Tremor Start of enrollment: 2004 Mar 01
Completed
Phase 2
Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor Start of enrollment: 2005 Jan 01
Completed
Phase 2
Botulinum Toxin to Treat Restless Legs Syndrome Start of enrollment: 2007 May 01
Completed
Phase 1, Phase 2
Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor Start of enrollment: 2009 Feb 01
Completed
Phase 1, Phase 2
The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias Start of enrollment: 2011 Jan 01
Completed
Octanoic Acid for Essential Tremor Start of enrollment: 2011 Oct 28
Completed
Phase 1
Trial of Cannabis for Essential Tremor Start of enrollment: 2019 Jan 22
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

An Algorithm for Automated Measurement of Kinetic Tremor Magnitude Using Digital Spiral Drawings.
Katherine Longardner, Qian Shen, Bin Tang, Brenton A Wright, Prantik Kundu
Digital Biomarkers. 2024-07-20
1 citations
Physiological and introspective antecedents of tics and movements in adults with tic disorders.
Antonio I Triggiani, Kaya Scheman, Sarah Pirio Richardson, Masao Matsuhashi, Elizabeth Peckham
Clinical Neurophysiology. 2023-07-01
3 citations
Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis.
Katherine Longardner, Brenton A Wright, Aljoharah Alakkas, Hyeri You, Ronghui Xu
Plos One. 2023-01-01

Press Mentions

Wearable PKG System Can Help Identify Parkinson’s Patients Eligible for Device-Assisted Therapy, Study ShowsJune 11th, 2019
Q&A: Feds Slowly Take Steps to Affirm the Medicinal Value of MarijuanaOctober 3rd, 2018
Nuplazid’s Mortality Risk Not Different from Seroquel, Combo Treatment, Study FindsSeptember 28th, 2018
Join now to see all

Grant Support

Functional Imaging Of Tremor Circuits And Mechanisms Of Treatment Response.National Institute Of Neurological Disorders And Stroke2011–2012

Professional Memberships

External Links

Physician Profilehttp://doctors.ucsd.edu/Details/22352?index=1&lastName=nahab
UCSD Movement Disorder Centerhttp://neurosciences.ucsd.edu/centers/movement-disorders/team/Pages/clinical.aspx